Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer

Nom du journal : Breast Cancer Res

Année : 2011

Volume : 13

Page de départ : 209

Auteurs: Regan MM, Price KN, Giobbie-Hurder A, Gelber RD, for the International Breast Cancer Study Group and BIG 1-98 Collaborative Group, Razafindratsira T,